$0.529900
-0.0021-0.39%
At Close: -
$0.560000
0.035.68%
After Hours: 2:34 PM EDT
15 minutes delayed
BioLine Rx
BLRXNASDAQ
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary
BioLine Rx Stock (NASDAQ: BLRX) stock price, news, charts, stock research, profile.
| Open | $0.54 |
| Close | $0.53 |
| Volume / Avg. | 299.44K / 384.79K |
| Day Range | 0.51 - 0.56 |
| 52 Wk Range | 0.52 - 2.53 |
| Market Cap | $44.77M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | - |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Bioline Rx Ltd
Sector
Health Care
Industry
Biotechnology
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's cu...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioLine Rx (BLRX) stock?
You can purchase shares of BioLine Rx (NASDAQ:BLRX) through any online brokerage.
Who are BioLine Rx (BLRX) competitors?
Other companies in BioLine Rx’s space includes: Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX), vTv Therapeutics (NASDAQ:VTVT) and Ocean Biomedical (NASDAQ:OCEA).
What is the target price for BioLine Rx (BLRX) stock?
There is no analysis for BioLine Rx.
What is the forecast for BioLine Rx (BLRX) stock?
BioLine Rx has a consensus price target of $12.50.
Current stock price for BioLine Rx (BLRX)?
The stock price for BioLine Rx (NASDAQ: BLRX) is $0.56 last updated Today at July 3, 2024 at 2:34 PM EDT.
Does BioLine Rx (BLRX) pay a dividend?
There are no upcoming dividends for BioLine Rx.
When is BioLine Rx (NASDAQ:BLRX) reporting earnings?
BioLine Rx’s Q2 earnings are confirmed for Wednesday, August 28, 2024.
Is BioLine Rx (BLRX) going to split?
There is no upcoming split for BioLine Rx.
What sector and industry does BioLine Rx (BLRX) operate in?
BioLine Rx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.